Categories
Uncategorized

Hakami developing stable cell line for production of exosomes carrying EIAV GP90 glycoprotein for vaccine development

Ramin Hakami, Associate Professor, School of Systems Biology, and researchers in his lab are purifying exosomes from the EIAV-gp90 cell line. They are doing so to demonstrate that exosomes have gp90 on the surface and can be used to develop a new type of vaccine for horses.  

Preliminary results generated will be used for future grant applications from the Center for Infectious Disease Research (CIDR) and Mason, and for collaborations among Mason, the virology firm Virongy, LLC, and Prince William County to promote regional economic development in the life science arena. “

For full article, click here